Citius Pharmaceuticals (CTXR) Return on Equity [ROE] (2016 - 2026)
Citius Pharmaceuticals (CTXR) recorded Return on Equity [ROE] of -80.23% in fiscal Q3 2026 (quarter ended Jun 30, 2026), down 16.07 percentage points from -64.17% a year earlier and down 12.01 percentage points from the prior quarter.
Powered by 
Analysis
Citius Pharmaceuticals (CTXR) Return on Equity [ROE] (2016 - 2026) Analysis & Trends
For FY2025 (ended Sep 30, 2025), Citius Pharmaceuticals reported Return on Equity [ROE] of -52.42%, down 4.78 percentage points from FY2024.
- Annual Return on Equity [ROE] has declined for four straight fiscal years, though with a five-year change of +5.28 percentage points (FY2020 to FY2025).
- Across earlier fiscal years, Return on Equity [ROE] came in at -47.63% in FY2024 (-14.23 pp), -33.40% in FY2023 (-4.92 pp), -28.48% in FY2022 (-0.78 pp) and -27.70% in FY2021 (+30.00 pp).
- The fiscal Q3 2026 figure is the lowest quarterly Return on Equity [ROE] in data going back to fiscal Q2 2016.
- On a year-over-year basis, Return on Equity [ROE] rose in two of the last eight quarters, with an average year-over-year change of -5.56 percentage points.
- Peak year-over-year performance for Return on Equity [ROE] in the last five years was a gain of 52.94 percentage points in fiscal Q1 2022, against a drop of 40.17 percentage points in fiscal Q4 2023 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at -68.23% (Q2 2026), -45.44% (Q1 2026) and -54.78% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.32% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 7.21% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 84.40% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 21.39% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 83.75% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -18.38% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.97% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 22.24% |
| 10 | Citius Pharmaceuticals | 14.55 Mn | 23.85 Mn | 1.00 Mn | -80.23% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -80.23% |
| Mar 31, 2026 | -68.23% |
| Dec 31, 2025 | -45.44% |
| Sep 30, 2025 | -54.78% |
| Jun 30, 2025 | -64.17% |
| Mar 31, 2025 | -65.58% |
| Dec 31, 2024 | -56.60% |
| Sep 30, 2024 | -49.16% |
| Jun 30, 2024 | -46.07% |
| Mar 31, 2024 | -43.80% |
| Dec 31, 2023 | -43.20% |
| Sep 30, 2023 | -71.11% |
| Jun 30, 2023 | -65.31% |
| Mar 31, 2023 | -31.53% |
| Dec 31, 2022 | -26.83% |
| Sep 30, 2022 | -30.94% |
| Jun 30, 2022 | -26.94% |
| Mar 31, 2022 | -22.90% |
| Dec 31, 2021 | -18.93% |
| Sep 30, 2021 | -17.24% |
API Access
Citius Pharmaceuticals Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CTXR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "CTXR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CTXR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();